Status:
RECRUITING
"Effect of Albumin Combined With Furosemide in Critically Ill Patients With Fluid Overload: Impact on Urine Output and Renal Function"
Lead Sponsor:
Jose J Zaragoza, MD MSc
Conditions:
Urine Output Decreased
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to compare the effectiveness of furosemide alone versus the combination of furosemide plus albumin in critically ill adult patients with fluid overload. The trial evaluates whether co-...
Detailed Description
This randomized clinical study evaluates two diuretic strategies for fluid overload in adult critically ill patients: furosemide monotherapy versus combined therapy with furosemide plus albumin. Album...
Eligibility Criteria
Inclusion Criteria:
Adults ≥ 18 years of age admitted to the intensive care unit (ICU) without mechanical ventilation.
Patients for whom diuretic therapy will be initiated for the first time during the ICU stay due to clinical signs of fluid overload, as determined by the treating physician.
Exclusion Criteria:
Patients or family members who refuse participation in the study.
Patients receiving palliative care.
Patients with kidney failure requiring renal replacement therapy.
Patients currently participating in another clinical research protocol.
Patients with clinical evidence of hypovolemia or dehydration.
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2026
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT07417969
Start Date
June 1 2025
End Date
October 31 2026
Last Update
February 18 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
76000
Querétaro City, Querétaro, Mexico, 26089